91. バッド・キアリ症候群 Budd-Chiari syndrome Clinical trials / Disease details


臨床試験数 : 4 薬物数 : 5 - (DrugBank : 4) / 標的遺伝子数 : 4 - 標的パスウェイ数 : 14

  
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1ChiCTR2100046725
2022-01-012021-05-27The efficacy and safety of Warfarin and Rivaroxaban to prevent re-occlusion for Budd-Chiari syndrome with membranous obstruction after percutanouse balloon angioplastyTo compare the efficacy and safety of Warfarin and Rivaroxaban to prevent re-occlusion for Budd-Chiari syndrome with membranous obstruction after percutanouse balloon angioplasty Budd-Chiari syndromeWarfarin group:oral take Warfarin;Rivaroxaban group:oral take rivaroxaban;The First Affiliated Hospital of Zhengzhou UniversityNULLRecruiting1875BothWarfarin group:40;Rivaroxaban group:40;N/AChina
2EUCTR2014-005162-29-NL
(EUCTR)
09/04/202013/06/2019Treatment of thrombosis in the abdominal veinsTreatment of portal, mesenteric, and splenic vein thrombosis with rivaroxaban. A pilot, prospective cohort study - RIVASVT100 Splanchnic vein thrombosis (SVT) is an unusual site manifestation of venous thromboembolism (VTE). It includes the Budd-Chiari syndrome (BCS), portal vein thrombosis (PVT), mesenteric vein thrombosis (MVT) and splenic vein thrombosis (spVT). PVT is the most frequent manifestation of SVT, followed by MVT. ;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]Trade Name: rivaroxaban 20 mg
Product Name: rivaroxaban
University of InsubriaNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
100Phase 4France;Canada;Germany;Netherlands;Italy
3ChiCTR1800017925
2018-08-312018-08-22D-printed bidirectional angiography versus traditional angiography for the diagnosis and effect of Budd–Chiari Syndrome With Inferior Vena Cava Obstruction:-----A Prospective Single blind Randomized TrialD-printed bidirectional angiography versus traditional angiography for the diagnosis and effect of Budd–Chiari Syndrome With Inferior Vena Cava Obstruction:-----A Prospective Single blind Randomized Trial Budd-Chiari syndromeGold Standard:traditional angiography;Index test:3D-printed bidirectional angiography;Affiliated Hospital of Xuzhou Medical UniversityNULLPending1968BothTarget condition:60;Difficult condition:0NULL
4JPRN-UMIN000015319
2012/06/0112/10/2014The efficacy of dabigatran for portal vein thrombosis/Budd-Chiari syndrome Portal vein thrombosis or Budd-Chiari syndromedabigatranChiba University Graduate School of Medicine, Department of Gastroenterology and NephrologyNULLRecruiting20years-old70years-oldMale and Female20Not selectedJapan